West L.A. biopharmaceutical firm CytRx Corp. reported positive results today from a study of a potential treatment for a form of brain cancer, the Wall Street Journal reports. The news sent shares up 42 cents, nearly 15 percent, in early trading.
11150 Santa Monica Boulevard, Suite 350
Los Angeles, CA 90025
323-549-5225
© Los Angeles Business Journal